Profound Medical Corp.

5.85
0.03 (0.52%)
At close: Apr 01, 2025, 3:59 PM
5.83
-0.41%
After-hours: Apr 01, 2025, 04:10 PM EDT

Profound Medical Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20
Net Income -27.82M -28.57M -28.67M -30.7M -21.62M
Depreciation & Amortization 936K 1.15M 1.6M 1.88M 1.54M
Stock-Based Compensation 2.58M 3.42M 4.24M 7.21M 3.02M
Other Working Capital -1.07M 78K -1.27M -26K 1.43M
Other Non-Cash Items 255K 1.1M 2.66M 425K 890K
Deferred Income Tax n/a 232K n/a -293K 237K
Change in Working Capital 591K 374K -5.63M -877K -4.63M
Operating Cash Flow -23.45M -22.3M -25.8M -22.36M -20.57M
Capital Expenditures n/a 0.19 n/a -593K -350K
Acquisitions n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a -709.4K -445.35K
Investing Cash Flow n/a n/a n/a -593K -350K
Debt Repayment -2.56M -1.2M 6.92M -386K -9.61M
Common Stock Repurchased n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a
Other Financial Acitivies -4.85M 2.67M 2.6M 7.91M 11.52M
Financial Cash Flow 54.7M 1.46M 7.03M 5.95M 87.43M
Net Cash Flow 28.7M -20.3M -20.64M -16.76M 69.11M
Free Cash Flow -23.45M -22.3M -25.8M -22.95M -20.92M